Related Experiment Video
Updated: Jun 21, 2026

Modeling Paracrine Noncanonical Wnt Signaling In Vitro
Published on: December 10, 2021
Wnt-5a-induced phosphorylation of DARPP-32 inhibits breast cancer cell migration in a CREB-dependent manner
Christian Hansen1, Jillian Howlin, Anders Tengholm
1Experimental Pathology, Department of Laboratory Medicine, Lund University, CRC, 205 02 Malmö, Sweden.
Abstract:
Tumor cell migration plays a central role in the process of cancer metastasis. We recently identified dopamine and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32) as an antimigratory phosphoprotein in breast cancer cells. Here we link this effect of DARPP-32 to Wnt-5a signaling by demonstrating that recombinant Wnt-5a triggers cAMP elevation at the plasma membrane and Thr34-DARPP-32 phosphorylation in MCF-7 cells. In agreement, both protein kinase A (PKA) inhibitors and siRNA-mediated knockdown of Frizzled-3 receptor or Galpha(s) expression abolished Wnt-5a-induced phosphorylation of DARPP-32. Furthermore, Wnt-5a induced DARPP-32-dependent inhibition of MCF-7 cell migration. Phospho-Thr-34-DARPP-32 interacted with protein phosphatase-1 (PP1) and potentiated the Wnt-5a-mediated phosphorylation of CREB, a well-known PP1 substrate, but had no effect on CREB phosphorylation by itself. Moreover, inhibition of the Wnt-5a/DARPP-32/CREB pathway, by expression of dominant negative CREB (DN-CREB), diminished the antimigratory effect of Wnt-5a-induced phospho-Thr-34-DARPP-32. Phalloidin-staining revealed that that the presence of phospho-Thr-34-DARPP-32 in MCF-7 cells results in reduced filopodia formation. In accordance, the activity of the Rho GTPase Cdc42, known to be crucial for filopodia formation, was reduced in MCF-7 cells expressing phospho-Thr-34-DARPP-32. The effects of DARPP-32 on cell migration and filopodia formation could be reversed in T47D breast cancer cells that were depleted of their endogenous DARPP-32 by siRNA targeting. Consequently, Wnt-5a activates a Frizzled-3/Galpha(s)/cAMP/PKA signaling pathway that triggers a DARPP-32- and CREB-dependent antimigratory response in breast cancer cells, representing a novel mechanism whereby Wnt-5a can inhibit breast cancer cell migration.
Insights
Wnt-5a signaling inhibits breast cancer cell migration by activating dopamine and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32). This novel pathway involves DARPP-32 phosphorylation, leading to reduced cell motility and filopodia formation.
Area of Science:
- Cell Biology
- Molecular Oncology
- Cancer Metastasis Research
Background:
- Tumor cell migration is critical for cancer metastasis.
- Dopamine and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32) is identified as an antimigratory phosphoprotein in breast cancer.
- The precise molecular mechanisms linking DARPP-32 to cell migration require further elucidation.
Purpose of the Study:
- To investigate the role of DARPP-32 in Wnt-5a signaling pathways.
- To elucidate the downstream molecular events mediating DARPP-32's antimigratory effects.
- To characterize the Wnt-5a/DARPP-32 signaling cascade in breast cancer cell migration.
Main Methods:
- Recombinant Wnt-5a stimulation of MCF-7 cells.
- Assessment of cAMP levels and DARPP-32 phosphorylation at Thr34.
- Inhibition studies using protein kinase A (PKA) inhibitors and siRNA-mediated knockdown of Frizzled-3 or Galpha(s).
- Analysis of cell migration, filopodia formation (Phalloidin staining), and Rho GTPase Cdc42 activity.
- Investigation of DARPP-32 interaction with protein phosphatase-1 (PP1) and CREB phosphorylation.
- Functional studies using dominant-negative CREB (DN-CREB) and DARPP-32 depleted T47D cells.
Main Results:
- Wnt-5a triggers cAMP elevation and Thr34-DARPP-32 phosphorylation in MCF-7 cells via Frizzled-3/Galpha(s)/PKA.
- Wnt-5a induces DARPP-32-dependent inhibition of MCF-7 cell migration and reduces filopodia formation by decreasing Cdc42 activity.
- Phospho-Thr-34-DARPP-32 interacts with PP1, potentiates Wnt-5a-mediated CREB phosphorylation, and this pathway is crucial for the antimigratory effect.
- The antimigratory effects of DARPP-32 were reversible in T47D cells depleted of endogenous DARPP-32.
Conclusions:
- Wnt-5a activates a Frizzled-3/Galpha(s)/cAMP/PKA signaling pathway.
- This pathway triggers a novel DARPP-32- and CREB-dependent antimigratory response in breast cancer cells.
- The findings reveal a new mechanism by which Wnt-5a can inhibit breast cancer cell migration and metastasis.
Related Concept Videos
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Non-Canonical Wnt Signaling Pathways
Cancer Cell Migration through Invadopodia
MAPK Signaling Cascades

